Certain identified information has been excluded from this exhibit because it is both (i) not material, and (ii) would likely cause competitive harm to the registrant if publicly disclosed. [***] indicates that information has been redacted....Separation Agreement • February 28th, 2024 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 28th, 2024 Company Industry JurisdictionThis Separation Agreement and General Release (“Agreement”) is entered into between Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) and Alicia Grande (“Employee”) (each individually, a “Party”, and collectively, the “Parties”). The Parties agree as follows:
Certain identified information has been excluded from this exhibit because it is both (i) not material, and (ii) would likely cause competitive harm to the registrant if publicly disclosed. [***] indicates that information has been redacted....Separation Agreement • February 28th, 2024 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 28th, 2024 Company Industry JurisdictionThis Separation Agreement and General Release (“Agreement”) is entered into between Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) and Patrick J. McEnany (“Employee”) (each individually, a “Party”, and collectively, the “Parties”). The Parties agree as follows: